Searched for
SUVEN EXECUTIVE
Cohance Lifesciences announces $10 million investment in US-based armCohance Lifesciences is investing USD 10 million to expand bioconjugation capabilities at its US subsidiary, NJ Bio, enhancing its ADC solu...- Suven Pharma shares in focus after Q3 profit jumps 78% YoY, revenue up 40%Suven Pharma reported a 78% YoY rise in Q3FY25 net profit to Rs 83.3 crore, with revenue growing 40% to Rs 307.2 crore, driven by its CDMO ...
- Suven Pharma sets sights on M&As to scale up tech expertise & order bookSuven Pharmaceuticals, backed by Advent International, is eyeing further mergers and acquisitions to bolster its capabilities and order boo...
- Suven Pharma to acquire 56 pc stake in US-based firm for USD 64.4 mnSuven Pharmaceuticals will acquire a 56% stake in US-based NJ Bio Inc for USD 64.4 million. This acquisition aligns with Suven's goal of be...
- Suven Pharmaceuticals names Vivek Sharma as executive chairmanSuven Pharma, backed by Advent International, has appointed Vivek Sharma as the new executive chairman effective September 20. Sharma bring...
- Stocks in news: L&T Finance, Ambuja Cement, Vodafone Idea, Puravankara, WiproEquity indices hit record levels on Thursday after lower-than-expected inflation hints at RBI interest rate cut. L&T Finance, Ambuja Cement...
- Suven Pharma to acquire controlling stake in Hyderabad-based CDMO Sapala OrganicSuven will initially acquire a 67.5% equity stake of Sapala subject to customary working capital and net debt adjustments, the remaining st...
- Pharma raw material makers in race to tank up on CXO talentSome of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded ...
- Suven, with Cohance and more, wants to become a CDMO powerhouse: Annaswamy Vaidheesh, executive chairman"We want to be a diversified, end-to-end capability outsourcing partner, serving customers from development to commercial scale. Doing this...
- Suven Pharmaceuticals shares soar 13% on proposed merger with Cohance LifesciencesShares of Suven Pharmaceuticals surged 13% on the NSE after proposing a merger with Cohance Lifesciences to strengthen its CDMO industry po...
- PE Advent completes acquisition of Suven Pharma, appoints new Board and management teamPrivate equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisati...
- Rs 15,800 crore worth block deals sealed this week. HDFC Bank, Zomato in top actionIn the mid cap segment, a dozen companies witnessed prominent block deals on-screen that were worth Rs 4,163 crore
- Advent International buys Suven Pharma for Rs 6,313 croreAdvent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...
- Buy Suven Pharmaceuticals, target price Rs 560: ICICI DirectSuven Pharmaceuticals Ltd., incorporated in the year 2018, is a Small Cap company (having a market cap of Rs 12075.29 Crore) operating in P...
- Buy Suven Pharma, target price Rs 575: ICICI DirectSuven Pharmaceuticals Ltd., incorporated in the year 2018, is a Small Cap company (having a market cap of Rs 12453.32 Crore) operating in P...
- Buy Suven Pharma, target price Rs 690: ICICI DirectThe brokerage says despite a significant run up, there is still scope for upside as the company is still trading at a significant discount ...
- Analyst Calls: Suven Life, Trent, NTPC, HDFCKotak Securities has re-initiated its coverage on Suven Life Sciences with a buy rating and set target price of Rs 445.
- Analyst Calls: Suven, Sadbhav Engineering, Future Lifestyle, PNC InfratechAnand Rathi has maintained its buy rating on Suven Life Sciences with a target price of Rs 387.
- Accumulate Suven Life Sciences, target Rs 238: SystematixThe 4QFY16 performance was driven by non-recurring elements like repeat orders from an innovator client and strong execution in specialty c...
- Suven Life gets patents for 2 neurodegenerative NCEsSuven Life Sciences' two chemical entities for treatment of disorders associated with neurodegenerative diseases have received patents from...
Load More
